Suppr超能文献

意大利医疗保健专业人员对儿童六价疫苗的偏好:态度与期望调查

Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations.

作者信息

Icardi Giancarlo, Orsi Andrea, Vitali Rosati Giovanni, Tognetto Alessia, Checcucci Lisi Giovanni, Parisi Salvatore

机构信息

Department of Health Sciences, University of Genoa, Italy.

Interuniversity Research Center on Influenza and Other Transmissible Infections (CIRI-IT), Genoa, Italy.

出版信息

J Prev Med Hyg. 2020 Oct 6;61(3):E424-E444. doi: 10.15167/2421-4248/jpmh2020.61.3.1535. eCollection 2020 Sep.

Abstract

INTRODUCTION

In Italy, three hexavalent pediatric vaccines are available: two are ready-to-use (RTU) as pre-filled syringes, while the third must be reconstituted (need-for-reconstitution [NFR]). The formulation is related to the vaccination timing, safety of preparation and administration, and possible errors in immunization. We surveyed Italian healthcare professionals (HCPs) experienced with RTU and NFR vaccines in order to investigate their opinions on key aspects of the vaccines.

METHODS

In Q1 2018, a qualitative study, ethnographic observations and in-depth interviews were performed in public vaccination settings of three Italian Regions. Data on how the vaccination process was managed and perceptions about the value of the RTU formulation were collected. In Q2 2018, face-to-face interviews were carried out to explore the attitude and preferences of Italian HCPs from nine Regions, assessing advantages and disadvantages of the two formulations from a quantitative point of view. In Q3-Q4 data analysis was carried out, using both qualitative and quantitative methodologies.

RESULTS

The first phase demonstrated the following advantages of the RTU versus the NFR formulation: time-saving, lower probability of needle contamination and needle stick incidents, better handling, simpler procedure, easier disposal of waste. For the survey, 149 HCPs were interviewed; 80% and 40%, respectively, were very satisfied with the RTU and NFR vaccine.

CONCLUSIONS

Our study demonstrated that HCPs prefer the RTU formulation, as it simplifies vaccinations, reduces preparation time and minimizes the risk of errors. This formulation also saves time that can be spent on more in-depth counseling.

摘要

引言

在意大利,有三种六价儿科疫苗可供使用:两种是预填充注射器形式的即用型(RTU),而第三种必须进行复溶(需复溶[NFR])。制剂形式与接种时间、制备和接种的安全性以及免疫过程中可能出现的错误有关。我们对有使用RTU和NFR疫苗经验的意大利医疗保健专业人员(HCP)进行了调查,以了解他们对这些疫苗关键方面的看法。

方法

2018年第一季度,在意大利三个地区的公共疫苗接种场所进行了定性研究、人种学观察和深入访谈。收集了关于疫苗接种过程如何管理以及对RTU制剂价值的看法的数据。2018年第二季度,进行了面对面访谈,以探究来自九个地区的意大利HCP的态度和偏好,从定量角度评估两种制剂的优缺点。在第三至第四季度进行了数据分析,采用了定性和定量方法。

结果

第一阶段表明,RTU制剂相对于NFR制剂具有以下优势:节省时间、针头污染和针刺事件的概率更低、操作更简便、程序更简单、废物处理更容易。在此次调查中,对149名HCP进行了访谈;分别有80%和40%的人对RTU和NFR疫苗非常满意。

结论

我们的研究表明,HCP更喜欢RTU制剂,因为它简化了疫苗接种过程,减少了准备时间,并将错误风险降至最低。这种制剂还节省了时间,可用于更深入的咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d41/7595078/c842df79ce47/jpmh-2020-03-e424-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验